PDS Biotechnology Corporation
PDSB
$0.29
-$0.01-2.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.45% | 35.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.37% | -2.30% | |||
| Operating Income | 0.37% | 2.30% | |||
| Income Before Tax | -32.68% | 2.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -32.68% | 2.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.68% | 2.83% | |||
| EBIT | 0.37% | 2.30% | |||
| EBITDA | 0.38% | 2.31% | |||
| EPS Basic | -32.33% | 9.69% | |||
| Normalized Basic EPS | -32.25% | 9.61% | |||
| EPS Diluted | -32.33% | 9.69% | |||
| Normalized Diluted EPS | -32.25% | 9.61% | |||
| Average Basic Shares Outstanding | 0.29% | 7.57% | |||
| Average Diluted Shares Outstanding | 0.29% | 7.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||